Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis.
Nishimura N, Onishi A, Yamamoto W, Nagai K, Shiba H, Okita Y, Son Y, Amuro H, Okano T, Ueda Y, Hara R, Katayama M, Yamada S, Hashimoto M, Maeda Y, Onizawa H, Fujii T, Murata K, Murakami K, Tanaka M, Matsuda S, Morinobu A.
Nishimura N, et al. Among authors: okano t.
Rheumatology (Oxford). 2024 Oct 30:keae603. doi: 10.1093/rheumatology/keae603. Online ahead of print.
Rheumatology (Oxford). 2024.
PMID: 39475445